Clinical Trial Update: A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase II clinical trial evaluating AL-37807 for open-angle glaucoma and ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• AL-37807

Snippet

Sponsor: Alcon Research | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED